Description

Velakast Velpatasvir Sofosbuvir Tablets: An Overview

Velakast Velpatasvir Sofosbuvir Tablets combine two direct-acting antivirals, Velpatasvir and Sofosbuvir, to treat chronic hepatitis C virus (HCV) infection. This combination works by inhibiting key proteins (NS5A and NS5B) essential for viral replication. Consequently, this makes it effective across all major HCV genotypes.

Usage and Administration

Doctors commonly prescribe Velakast  Tablets as a once-daily oral therapy for adults with chronic hepatitis C, with or without cirrhosis. Patients may use it with Ribavirin in certain cases, depending on their medical history. Treatment duration typically lasts 12 weeks but may vary based on the individual’s viral load and prior treatment status.

Manufacturing and Safety

Aprazer Healthcare Pvt Ltd. manufactures Velakast Velpatasvir Sofosbuvir Tablets. Regular monitoring of liver function, viral load, and overall response to therapy is advised during the treatment course. Patients are encouraged not to skip doses and to avoid alcohol or other liver-damaging substances during therapy.

Availability and Purchase

Genetec Lifesciences makes Velakast Tablets available. To place an order or request a quote, contact us directly. We ensure that we source all products from verified and authorized vendors.

Disclaimer

Product information mentioned on this site is for informative purposes only. The product image belongs to its respective company. Genetec Lifesciences acts as a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or its authorized vendors.